Pharmaceutical PV DIV - FSB
Ended Awarded Last action
- Contract number
- SPE2DU26FEEEW
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $29,877
Award facts
- Contract value 100% obligated
- $29,876.52 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Park Ridge, IL 60068, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency (DLA) awarded a $29,876.52 firm fixed-price delivery order to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. This delivery order, issued on December 22, 2025, with an ultimate completion date of December 23, 2025, carries no set-aside designation and represents a routine procurement under DMS Pharmaceutical Group's existing Indefinite Delivery Contract (IDC) with DLA. The company will supply pharmaceutical products and medical consumables to support Department of Defense healthcare operations, drawing from its extensive portfolio that includes branded and generic prescription medications, biologics, vaccines, specialty pharmaceuticals, and medical devices.
This delivery order operates under DMS Pharmaceutical Group's single-award IDC established through DLA's Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V) initiative, a $30.3 billion government-wide acquisition strategy awarded on November 13, 2025, with a $499.9 million ceiling value and performance extending through December 31, 2036. The PPV-G GEN V program designates regional prime vendor contractors to provide comprehensive pharmaceutical supplies to military healthcare facilities worldwide on a recurring basis. DMS Pharmaceutical Group's appointment as a prime vendor reflects its competitive capability in unrestricted federal procurement and its demonstrated performance across multiple therapeutic categories supporting the Department of Defense's global medical supply chain requirements.
Quick answers
Who was awarded contract SPE2DU26FEEEW?
SPE2DU26FEEEW was awarded to DMS Pharmaceutical Group Inc. by Defense Logistics Agency (Department of Defense) on December 22, 2025.
How much is contract SPE2DU26FEEEW worth?
The government has obligated $29,877 on SPE2DU26FEEEW.
Is contract SPE2DU26FEEEW an order under another contract?
Yes. SPE2DU26FEEEW is a delivery order under SPE2DU25D9439, an indefinite delivery contract.
Was contract SPE2DU26FEEEW competed?
The extent of competition for SPE2DU26FEEEW was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award